Your browser doesn't support javascript.
loading
Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil.
Pachito, Daniela V; Eckeli, Alan L; Drager, Luciano F.
Afiliação
  • Pachito DV; Prossono Centro de Diagnóstico e Medicina do Sono, Ribeirão Preto, Sao Paulo, Brazil. Electronic address: pachito@uol.com.br.
  • Eckeli AL; Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Sao Paulo, Brazil.
  • Drager LF; Unidade de Hipertensão, Instituto do Coração (InCor) do Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil; Unidade de Hipertensão, Disciplina de Nefrologia, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.
Value Health Reg Issues ; 40: 81-88, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38056224
OBJECTIVES: This study aimed to conduct a cost-utility analysis of continuous positive airway pressure (CPAP) therapy compared with usual care as treatment of moderate to severe cases of obstructive sleep apnea (OSA) in Brazil, where decentralized policies of CPAP provision are in place. METHODS: Markov cohort model comparing CPAP therapy with usual care, that is, no specific treatment for OSA, for moderate to severe cases was used. The payer perspective from the Unified Health System, Brazil, was adopted. Effectiveness parameters and costs related to health states were informed by literature review. Resource use related to CPAP therapy was defined by specialists and costs informed by recent purchase and leasing contracts. Incremental cost-effectiveness ratios were generated for purchase and leasing contracts to reflect current practices. A conservative willingness-to-pay threshold was set at 1 gross domestic product per capita per quality-adjusted life-year (QALY) (Brazilian reais [BRL] 40 712/QALY). Uncertainties were explored in deterministic and probabilistic sensitivity analyses. RESULTS: Incremental cost-effectiveness ratio for the purchase modality was 8303 BRL/QALY and for leasing 45 192 BRL/QALY. Considering the adopted willingness-to-pay threshold, provision of CPAP by the purchase modality was considered cost-effective but not the leasing modality. The parameter related to the greatest uncertainty was the reduction in the risk of having a stroke attributable to CPAP. Probabilistic analysis confirmed the robustness of results. CONCLUSIONS: CPAP therapy is a cost-effective alternative compared with usual care for moderate to severe OSA for the purchase modality. These results should help underpinning the decision making related to a uniform policy of CPAP provision across the country.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Pressão Positiva Contínua nas Vias Aéreas Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Pressão Positiva Contínua nas Vias Aéreas Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos